Extending the evidence: What did the FOURIER trial teach us on managing high-risk patients?

Media formats available:

Insights and lessons from the ODYSSEY Outcomes trial: Which patients benefit most?
Insights and lessons from the ODYSSEY Outcomes trial: Which patients benefit most?
PCSK9i, changing practice in cardiology: The emerging story
Insights and lessons from the ODYSSEY Outcomes trial: Which patients benefit most?
- Prof. Ph. Gabriel Steg, MD
Targeting PCSK9: Expanding knowledge and targeting new frontiers
Targeting PCSK9: Expanding knowledge and targeting new frontiers
PCSK9i, changing practice in cardiology: The emerging story
Targeting PCSK9: Expanding knowledge and targeting new frontiers
- Prof. John Kastelein, MD

PACE-CME